Table 2 Participant baseline characteristics
| 听 | Standard clinic (n鈥�=鈥�18) | Text message-enhanced clinic (n鈥�=鈥�18) | Overall (n鈥�=鈥�36) |
|---|---|---|---|
Age (years) | 61.3鈥壜扁赌�9.1 | 68.3鈥壜扁赌�9.1 | 64.8鈥壜扁赌�9.6 |
Body mass index (kg/m2) | 26.1鈥壜扁赌�4.2 | 26.5鈥壜扁赌�3.9 | 26.3鈥壜扁赌�4.0 |
Gender (male) | 11 (61%) | 12 (67%) | 23 (64%) |
Primary cancer | |||
鈥僀辞濒辞谤别肠迟补濒 | 12 (67%) | 13 (72%) | 25 (69%) |
鈥働谤辞蝉迟补迟别 | 5 (28%) | 5 (28%) | 10 (28%) |
鈥傿谤别补蝉迟 | 1 (6%) | 0 (0%) | 1 (3%) |
Number of medications | |||
鈥僋辞苍别 | 4 (22%) | 4 (22%) | 8 (22%) |
鈥�1 | 3 (17%) | 2 (11%) | 5 (14%) |
鈥冣赌夆墺鈥�2 | 11 (61%) | 12 (67%) | 23 (64%) |
Post-diagnosis (months) | 54.5 (38.0, 72.0) | 60.0 (47.0, 71.0) | 57.5 (43.5, 71.5) |
Post treatment (months) | 38.5 (25.0, 66.0) | 51.0 (10.0, 61.0) | 46.0 (24.5, 61.0) |
Activity (activPAL micro)a | |||
鈥僕ear time (h) | 15.7鈥壜扁赌�0.7 | 15.9鈥壜扁赌�0.9 | 15.8鈥壜扁赌�0.8 |
鈥僑itting (h/16鈥塰) | 9.4鈥壜扁赌�2.1 | 9.5鈥壜扁赌�1.8 | 9.4鈥壜扁赌�1.9 |
鈥働rolonged sitting (h/16鈥塰) | 4.6鈥壜扁赌�2.2 | 4.7鈥壜扁赌�1.8 | 4.7鈥壜扁赌�2.0 |
鈥僑tanding (h/16鈥塰) | 4.3鈥壜扁赌�1.5 | 4.3鈥壜扁赌�1.3 | 4.3鈥壜扁赌�1.4 |
鈥僑tepping (h/16鈥塰) | 2.4鈥壜扁赌�0.8 | 2.1鈥壜扁赌�0.7 | 2.3鈥壜扁赌�0.8 |
鈥僉ight stepping (min/16鈥塰) | 95.3鈥壜扁赌�26.3 | 98.2鈥壜扁赌�22.8 | 96.7鈥壜扁赌�24.3 |
鈥僊VPA (min/16鈥塰) | 43.7鈥壜扁赌�28.8 | 31.1鈥壜扁赌�19.4 | 37.4鈥壜扁赌�25 |